The CHEK2 Del5395 is a Founder Mutation Without Direct Effects for Cancer Risk in the Latvian Population

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The CHEK2 Del5395 is a Founder Mutation Without Direct Effects for Cancer Risk in the Latvian Population'. Together they form a unique fingerprint.

    Medicine and Dentistry